Actively Recruiting
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
Led by Le Thi Kieu Trang · Updated on 2025-03-13
180
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to assess the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) for prophylactic pain relief compared to on-demand pain relief during medical abortion for pregnancies between 13 and 22 weeks at Hung Vuong Hospital in Ho Chi Minh City. The main questions it aims to answer are: 1. Does prophylactic use of NSAIDs reduce pain compared to on-demand use during medical abortion? 2. What are the potential adverse effects of NSAIDs in this context? Researchers will compare a group receiving prophylactic NSAIDs to a control group receiving on-demand pain relief to determine if the prophylactic approach leads to improved pain management outcomes. Participants will: * Be given NSAIDs either as a preventative measure or upon the onset of pain. * Be monitored for pain levels using validated pain scales, any side effects, and outcomes of the abortion procedure.
CONDITIONS
Official Title
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 18 years or older
- No mental illness
- Gestational age between 13 and 22 weeks based on last menstrual period or first-trimester ultrasound
- Indication for abortion includes stillbirth, fetal malformation requiring termination, or voluntary abortion with counseling
- Willing to participate in the study
- Able to read and sign the informed consent form
- Able to provide personal information independently
You will not qualify if you...
- Medical conditions preventing medical abortion: bleeding disorders, anticoagulant use, moderate to severe anemia
- Cardiovascular conditions: heart failure, mitral valve stenosis, embolism, uncontrolled hypertension
- Other medical conditions: renal failure, adrenal gland disorders, severe asthma, liver and biliary diseases, glaucoma
- Active pelvic inflammatory disease or acute genital infections
- Previous uterine surgery
- Placenta previa or central placenta previa
- Uterine malformations
- History of allergy to NSAIDs, Mifepristone, or Misoprostol
- Unwillingness to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hung Vuong Hospital
Ho Chi Minh City, Vietnam
Actively Recruiting
Research Team
L
Le Trang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here